Target
Histone-lysine N-methyltransferase EZH2 [Y641F]
Ligand
BDBM516837
Substrate
n/a
Meas. Tech.
In Vitro Methyltransferase Activity Assay
IC50
9.00±n/a nM
Citation
 Peng, JLiu, YWang, LFang, ZFei, ZChen, XLan, J 4,5,6-trisubstituted indazole derivatives, and preparation method and pharmaceutical use thereof US Patent  US11104664 Publication Date 8/31/2021 
Target
Name:
Histone-lysine N-methyltransferase EZH2 [Y641F]
Synonyms:
EZH2 | EZH2(Y641F) | EZH2_HUMAN | Histone-lysine N-methyltransferase EZH2 (Y641F) | KMT6
Type:
n/a
Mol. Mass.:
85351.84
Organism:
Homo sapiens (Human)
Description:
Q15910[Y641F]
Residue:
746
Sequence:
MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEFCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP
  
Inhibitor
Name:
BDBM516837
Synonyms:
US11104664, Compound P-9
Type:
Small organic molecule
Emp. Form.:
C30H44N6O3
Mol. Mass.:
536.7088
SMILES:
CCN(C1CCC(CC1)N(C)CCOC)c1c(C)c(cc2n(C)ncc12)C(=O)NCc1c(C)cc(C)[nH]c1=O |(3.59,-2.55,;3.59,-1.01,;4.92,-.24,;6.26,-1.01,;7.59,-.24,;8.93,-1.01,;8.93,-2.55,;7.59,-3.32,;6.26,-2.55,;10.26,-3.32,;11.59,-2.55,;10.26,-4.86,;11.59,-5.63,;11.59,-7.17,;12.93,-7.94,;4.92,1.3,;6.26,2.07,;7.59,1.3,;6.26,3.61,;4.92,4.38,;3.59,3.61,;2.13,4.09,;1.65,5.55,;1.22,2.84,;2.13,1.6,;3.59,2.07,;7.59,4.38,;8.93,3.61,;7.59,5.92,;8.93,6.69,;8.93,8.23,;10.26,9,;11.59,8.23,;10.26,10.54,;8.93,11.31,;8.93,12.85,;7.59,10.54,;7.59,9,;6.26,8.23,)|
Structure:
Search PDB for entries with ligand similarity: